Adapting treatment and follow-up according to the risk of recurrence and/or death from thyroid cancer is a relatively recent concept of "personnalized" medicine, developed particularly to avoid overtreatment of low-risk thyroid cancer which represents the majority of thyroid cancers diagnosed in the world today. For low-risk thyroid cancer, this decrease in extent of treatment involves the extent of surgery-total thyroidectomy, lobectomy or no surgery with active surveillance-but also the indications, doses and methods of stimulation when or if administering radioactive iodine (RAI), the indication for suppressive thyroxin therapy and the extent and modalities for follow-up that should be adapted to the risk of recurrence. The aim is to optimize medical resources and quality of life, particularly for low-risk patients whose life expectancy is that of the general population.

中文翻译：

---

以风险为导向的甲状腺内乳头状甲状腺癌治疗概念。

根据甲状腺癌复发和/或死亡的风险调整治疗和随访是相对近期的“个性化”药物概念，其开发目的是避免过度治疗低危甲状腺癌，因为低危甲状腺癌代表了在甲状腺癌中诊断出的大多数甲状腺癌。今天的世界。对于低危甲状腺癌，这种治疗程度的降低涉及手术的程度，包括全甲状腺切除术，肺叶切除术或没有进行主动监测的手术，而且还涉及当或如果使用放射性碘（RAI）时的适应症，剂量和刺激方法，抑制性甲状腺素治疗的适应症以及应适应复发风险的随访范围和方式。目的是优化医疗资源和生活质量，